Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean cerlapirdine of pf 5212365 of sar 551 of セルラピリジン?
Displaying drugs 76 - 100 of 183 in total

Gefapixant

It has been estimated that 5-10% of adults globally suffer from chronic cough, which is defined as a cough lasting longer than eight weeks. A subset of these patients remain symptomatic despite thorough investigation and treatment, termed refractory chronic cough (RCC) if they have a cough that does not respond...
Approved
Investigational
Matched Description: … refractory chronic cough (RCC) if they have a cough that does not respond to conventional treatment or ... [L48596,L48591] It is the first therapy to be approved for the treatment of RCC or UCC in the EU. ... cough have been associated with considerable side effects, in particular opioids such as [codeine] or …

Dexamethasone

Dexamethasone, or MK-125, is a corticosteroid fluorinated at position 9 used to treat endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions. Developed in 1957, it is structurally similar to other corticosteroids like hydrocortisone and prednisolone. Dexamethasone was granted FDA approval on 30 October 1958....
Approved
Investigational
Vet approved
Matched Description: … Dexamethasone, or MK-125, is a corticosteroid fluorinated at position 9 used to treat endocrine, rheumatic …
Matched Mixtures name: … Dex-Moxi PF ... DexMoxiKetor PF …
Matched Products: … DEKSAMETAZON-PF 8 MG/2 ML I.M./I.V. ENJEKSİYONLUK ÇÖZELTİ, 1 ADET …

Betamethasone

Betamethasone is a long-acting corticosteroid with immunosuppressive and antiinflammatory properties. It can be used topically to manage inflammatory skin conditions such as eczema, and parenterally to manage several disease states including autoimmune disorders. Betamethasone has potent glucocorticoid activity and negligible mineralocorticoid activity.
Approved
Vet approved
Matched Mixtures name: … Betamethasone Combo 6mg/mL PF ... Betamethasone Combo 6mg/mL PF …
Matched Products: … Betamethasone SP 24mg/2mL PF …

Lactic acid

A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed) Sodium lactate is the sodium salt of lactic acid, and has a mild saline taste. It is produced by fermentation of a sugar source, such as...
Approved
Vet approved
Matched Description: … It is produced by fermentation of a sugar source, such as corn or beets, and then, by neutralizing the …
Matched Mixtures name: … PF LAKTATLI RİNGER IV İNFÜZON İÇİN ÇÖZELTİ, 500 ML SETLİ ... PF LAKTATLI RİNGER IV İNFÜZON İÇİN ÇÖZELTİ, 1000 ML SETLİ ... PF LAKTATLI RİNGER IV İNFÜZON İÇİN ÇÖZELTİ, 500 ML SETSİZ …

Eucalyptus oil

Eucalyptus oil is a distilled oil derived from the leaves of the tree Eucalyptus. It is shown to be effective in reducing pain, swelling, and inflammation via its modulatory effect on the immune response. It is also shown to exhibit antibacterial activity against some bacterial species and cough suppressant actions....
Approved
Matched Mixtures name: … SAM SEEH BRAND LINIMENT …

Cefdinir

Cefdinir, also known as Omnicef, is a semi-synthetic, broad-spectrum antibiotic belonging to the third generation of the cephalosporin class. It has been proven to be effective for the treatment of common bacterial infections in the ear, sinus, throat, lungs, and skin. Cefdinir was approved by the FDA in 1997 to...
Approved

Camphor

Camphor is a bicyclic monoterpene ketone found widely in plants, especially Cinnamomum camphora. It is used topically as a skin antipruritic and as an anti-infective agent. When ingested, camphor has a rapid onset of toxic effects, and camphorated oil is the product most often responsible for its toxicity. The FDA...
Approved
Withdrawn
Matched Description: … It appears in the list of drug products withdrawn or removed from the market for safety or effectiveness …
Matched Mixtures name: … SAM SEEH BRAND LINIMENT …

Levomenthol

Menthol is a covalent organic compound made synthetically or obtained from peppermint or other mint oils. Forming clear or white waxy, crystalline substance, menthol is typically solid at room temperature. (-)-Menthol is the naturally-occurring and main form of menthol, and is assigned the (1R,2S,5R) configuration. Menthol mediates anesthetic properties and...
Approved
Matched Description: … Menthol is a covalent organic compound made synthetically or obtained from peppermint or other mint oils ... Forming clear or white waxy, crystalline substance, menthol is typically solid at room temperature. ( …
Matched Mixtures name: … SAM SEEH BRAND LINIMENT …

Glasdegib

Glasdegib, also known as PF-04449913, is a small-molecule hedgehog signaling inhibitor selected under the group of benzimidazoles. In early research, benzimidazoles attracted large interest as they represented a class of inhibitors with low molecular weight, potent inhibitory activity, and lacking unstable functionality. The great lipophilicity of this group of compounds...
Approved
Investigational
Matched Description: … Glasdegib, also known as PF-04449913, is a small-molecule hedgehog signaling inhibitor selected under ... Aberrant of Hh signaling is one of the main pathophysiologies of AML, with observed overexpression or …

Magnesium chloride

Magnesium chloride salts are highly soluble in water and the hydrated form of magnesium chloride can be extracted from brine or sea water.
Approved
Matched Description: … are highly soluble in water and the hydrated form of magnesium chloride can be extracted from brine or …
Matched Mixtures name: … Dextrose 50% Inj W Electrolytes PF Abbovac ... PF İZOLEN DENGELİ ELEKTROLİT İV İNFÜZON İÇİN ÇÖZELTİ, 500 ML SETLİ ... PF İZOLEN DENGELİ ELEKTROLİT İV İNFÜZON İÇİN ÇÖZELTİ, 1000 ML SETLİ …

Benzalkonium

Benzalkonium is a quaternary ammonium compound used as a biocide, a cationic surfactant, and as a phase transfer agent [FDA Label]. Benzalkonium is more commonly contained in consumer products in its salt form, benzalkonium chloride [FDA Label]. This salt is used in a great variety of international pharmaceutical products such...
Approved
Investigational
Matched Description: … used in a great variety of international pharmaceutical products such as eye, ear, and nasal drops or …
Matched Categories: … Compounds used in a research, industrial, or household setting …
Matched Products: … Trick or Treat Antibacterial Foaming Hand Wash ... PF Anti-bacterial Hand Sanitizing Wipes ... PF Foaming Anti-bacterial Hand Sanitizing …

Menthol

Approved
Matched Products: … Kerasal PF-10 …

Cerlapirdine

Cerlapirdine has been investigated for the treatment of Alzheimer Disease.
Investigational
Matched Synonyms: … Cerlapirdine …
Matched Name: … Cerlapirdine …
Matched Description: … Cerlapirdine has been investigated for the treatment of Alzheimer Disease. …
Matched Salts name: … Cerlapirdine Hydrochloride …

PF-232798

PF-232798 is under investigation in clinical trial NCT01140425 (Study To Evaluate The Effect Of A Multiple Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects).
Investigational
Matched Synonyms: … PF-00232798 …
Matched Name: … PF-232798 …
Matched Description: … Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects). ... PF-232798 is under investigation in clinical trial NCT01140425 (Study To Evaluate The Effect Of A Multiple …

PF-06821497

PF-06821497 is under investigation in clinical trial NCT03460977 (PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma).
Investigational
Matched Name: … PF-06821497 …
Matched Description: … PF-06821497 is under investigation in clinical trial NCT03460977 (PF-06821497 Treatment Of Relapsed/Refractory …

PF-04937319

PF-04937319 is under investigation in clinical trial NCT01513928 (A Study To Compare The Pharmacokinetics Of Different Formulations Of PF-04937319 In Healthy Subjects).
Investigational
Matched Name: … PF-04937319 …
Matched Description: … Of Different Formulations Of PF-04937319 In Healthy Subjects). ... PF-04937319 is under investigation in clinical trial NCT01513928 (A Study To Compare The Pharmacokinetics …

PF-06650833

PF-06650833 is under investigation in clinical trial NCT02609139 (Study to Evaluate Pharmacokinetics of A Modified Release Formulation of PF-06650833 in Healthy Subjects).
Investigational
Matched Name: … PF-06650833 …
Matched Description: … of A Modified Release Formulation of PF-06650833 in Healthy Subjects). ... PF-06650833 is under investigation in clinical trial NCT02609139 (Study to Evaluate Pharmacokinetics …

PF-06282999

Pf 06282999 is under investigation in clinical trial NCT01626976 (A Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects).
Investigational
Matched Name: … PF-06282999 …
Matched Description: … And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects). ... Pf 06282999 is under investigation in clinical trial NCT01626976 (A Study To Assess The Safety, Tolerability …

PF-05089771

PF-05089771 is under investigation in clinical trial NCT01529671 (A Safety And Tolerability Study Of PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee).
Investigational
Matched Name: … PF-05089771 …
Matched Description: … PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee). ... PF-05089771 is under investigation in clinical trial NCT01529671 (A Safety And Tolerability Study Of …

PF-06751979

PF-06751979 is under investigation in clinical trial NCT03126721 (The Study is to Evaluate the Effect of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults).
Investigational
Matched Name: … PF-06751979 …
Matched Description: … of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults). ... PF-06751979 is under investigation in clinical trial NCT03126721 (The Study is to Evaluate the Effect …

PF-06882961

PF-06882961 is under investigation in clinical trial NCT03985293 (A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus).
Investigational
Matched Name: … PF-06882961 …
Matched Description: … and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus). ... PF-06882961 is under investigation in clinical trial NCT03985293 (A 16 Week Study to Evaluate the Efficacy …

PF-04856884

PF-04856884 or CVX-060 is a selective angiopoietin (Ang)-2 inhibitor. It is under investigation in clinical trial NCT01441414 (PF-04856884 (CVX-060) in Combination With Axitinib in Patients With Previously Treated Metastatic Renal Cell Carcinoma).
Investigational
Matched Name: … PF-04856884 …
Matched Description: … PF-04856884 or CVX-060 is a selective angiopoietin (Ang)-2 inhibitor. ... [A257291] It is under investigation in clinical trial NCT01441414 (PF-04856884 (CVX-060) in Combination …

PF-04447943

PF-04447943 has been investigated for the treatment of Alzheimer's Disease.
Investigational
Matched Name: … PF-04447943 …
Matched Description: … PF-04447943 has been investigated for the treatment of Alzheimer's Disease. …

PF-03882845

PF-03882845 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 and Type 2 Diabetic Nephropathy.
Investigational
Matched Name: … PF-03882845 …
Matched Description: … PF-03882845 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 and Type …

PF-04958242

PF-04958242 has been used in trials studying the basic science and treatment of Schizophrenia and Hearing Loss, Sensorineural.
Investigational
Matched Name: … PF-04958242 …
Matched Description: … PF-04958242 has been used in trials studying the basic science and treatment of Schizophrenia and Hearing …
Displaying drugs 76 - 100 of 183 in total